[HTML][HTML] miR-451a is underexpressed and targets AKT/mTOR pathway in papillary thyroid carcinoma
E Minna, P Romeo, M Dugo, L De Cecco, K Todoerti… - Oncotarget, 2016 - ncbi.nlm.nih.gov
Abstract Papillary Thyroid Carcinoma (PTC) is the most frequent thyroid cancer. Although
several PTC-specific miRNA profiles have been reported, only few upregulated miRNAs are …
several PTC-specific miRNA profiles have been reported, only few upregulated miRNAs are …
Advancements in the treatment of differentiated thyroid cancer
LA Stewart, JH Kuo - Therapeutic Advances in …, 2021 - journals.sagepub.com
Derived from follicular epithelial cells, differentiated thyroid cancer (DTC) accounts for the
majority of thyroid malignancies. The threefold increase in DTC incidence over the last three …
majority of thyroid malignancies. The threefold increase in DTC incidence over the last three …
First evidence of PSMA expression in differentiated thyroid cancer using [68Ga]PSMA-HBED-CC PET/CT
FA Verburg, T Krohn, A Heinzel, FM Mottaghy… - European journal of …, 2015 - Springer
Eur J Nucl Med Mol Imaging (2015) 42: 1622–1623 DOI 10.1007/s00259-015-3065-y the
expression of PSMA in the neovasculature of differentiated thyroid cancer (DTC).[68Ga] …
expression of PSMA in the neovasculature of differentiated thyroid cancer (DTC).[68Ga] …
[HTML][HTML] Trop2 enhances invasion of thyroid cancer by inducing MMP2 through ERK and JNK pathways
H Guan, Z Guo, W Liang, H Li, G Wei, L Xu, H Xiao, Y Li - Bmc Cancer, 2017 - Springer
Background Mounting evidence has showed that Tumor-associated calcium signal
transducer 2 (Trop2) is upregulated in various kinds of human cancers and plays important …
transducer 2 (Trop2) is upregulated in various kinds of human cancers and plays important …
Prognostic classifier based on genome-wide DNA methylation profiling in well-differentiated thyroid tumors
M Bisarro dos Reis, MC Barros-Filho… - The Journal of …, 2017 - academic.oup.com
Context Even though the majority of well-differentiated thyroid carcinoma (WDTC) is
indolent, a number of cases display an aggressive behavior. Cumulative evidence suggests …
indolent, a number of cases display an aggressive behavior. Cumulative evidence suggests …
[HTML][HTML] Function and clinical significance of circular RNAs in thyroid cancer
X Yao, Q Zhang - Frontiers in molecular biosciences, 2022 - frontiersin.org
Thyroid cancer (TC) is the leading cause and mortality of endocrine malignancies
worldwide. Tumourigenesis involves multiple molecules including circular RNAs (circRNAs) …
worldwide. Tumourigenesis involves multiple molecules including circular RNAs (circRNAs) …
Role of differentially expressed genes and long non‐coding RNAs in papillary thyroid carcinoma diagnosis, progression, and prognosis
WY Cai, X Chen, LP Chen, Q Li, XJ Du… - Journal of cellular …, 2018 - Wiley Online Library
Currently, the combination of ultrasonography and fine‐needle aspiration biopsy (FNAB)
can not discriminate between benign and malignant tumor of thyroid in some cases. The …
can not discriminate between benign and malignant tumor of thyroid in some cases. The …
[HTML][HTML] Preoperative lymph node staging by FDG PET/CT with contrast enhancement for thyroid cancer: a multicenter study and comparison with neck CT
A Chong, JM Ha, YH Han, E Kong… - Clinical and …, 2017 - synapse.koreamed.org
Objectives The purpose of this study was to compare lymph node (LN) staging using 18 F-
fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) …
fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) …
[HTML][HTML] SREBP1 as a potential biomarker predicts levothyroxine efficacy of differentiated thyroid cancer
C Li, X Peng, J Lv, H Zou, J Liu, K Zhang, Z Li - Biomedicine & …, 2020 - Elsevier
Background SREBP1 is a well-known transcript factor regulating lipogenesis. It has been
reported to play an important role in tumor progress in recent years. However, the roles of …
reported to play an important role in tumor progress in recent years. However, the roles of …
Emerging strategies for managing differentiated thyroid cancers refractory to radioiodine
S Bulotta, M Celano, G Costante, D Russo - Endocrine, 2016 - Springer
Efficient treatment of radio refractory thyroid cancer is still a major challenge. The recent
identification of genetic and epigenetic alterations present in almost all differentiated tumors …
identification of genetic and epigenetic alterations present in almost all differentiated tumors …